Allergan to Request Court Block Valeant and Pershing Square from Voting Shares Acquired in Violation of Insider Trading LawsAugust 27, 2014 8:27 am | News | Comments
Allergan has asked the United States District Court for the Central District of California to set an expedited schedule for discovery and a motion for a preliminary injunction against Valeant Pharmaceuticals, Pershing Square Capital Management, L.P., and its principal, William A. Ackman, for violations of the federal securities laws.
Bristol-Myers Squibb Company today announced that the European Commission has approved Daklinza (daclatasvir) for use in combination with other medicinal products across genotypes 1, 2, 3 and 4 for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Tris Pharma Selected as an Award Winner in the New Jersey Business & Industry Association's 2014 Awards for ExcellenceAugust 27, 2014 8:16 am | News | Comments
Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has been selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence competition in the Business Expansion category.
Ligand Pharmaceuticals Incorporated announced that its partner GlaxoSmithKline has received approval of a supplemental New Drug Application (sNDA) for the once-daily use of Promacta®/Revolade™ (eltrombopag) in patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST).
The alliance is intended to encompass a long-term supply agreement in which EMD Millipore will provide raw materials for biopharmaceutical manufacturing.
Due to the special containment requirements for manufacturing highly potent active pharmaceutical ingredients and cytotoxic drugs, we have seen many CMO’s invest in building additional capacity in this area. While there are tremendous benefits and a strong promise with these types of products there are also considerable challenges and risks associated with their production, especially in a multiproduct CMO environment.
That’s Nice LLC, a research-focused strategic marketing agency dedicated to life science markets, today announced the formation of a new dedicated team that will support clients with comprehensive strategic content development.
Fresenius Kabi announced today it has received approval from the U.S. Food and Drug Administration for Kabiven ® and Perikabiven ®, parenteral nutrition (PN) products in a three-chamber bag – the only container of its kind available in the United States.
Daily doses of aspirin could help reduce the risk of recurring blood clots, researchers say. Also, a study from Stanford University found that about one in seven people have what it calls "sleep drunkenness."
PhRMA launched a new Innovation Hub to showcase the latest data and research on innovation in the biopharmaceutical industry. The new Innovation Hub, accessible via www.Innovation.org, provides easy access to PhRMA resources related to the R&D process, the biopharmaceutical pipeline, and progress fighting diseases.
Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Robert Hureau as executive vice president and chief financial officer. Hureau brings 25 years of experience and extensive financial expertise spanning the medical technology/life sciences, manufacturing and consumer sectors.
In recent years genetic testing has been introduced. It has caused a bit of for and against uproar. Information from this testing could be used for changing the lifestyle that could avert diseases one might encounter with age or even could be used for personalized medicine. Better lifestyle could lower pharma sales and an unacceptable scenario by the current players.
The Veterans Affairs Department says investigators have found no proof that delays in care caused any deaths at a VA hospital in Phoenix, deflating an explosive allegation that helped expose a troubled health care system in which veterans waited months for appointments while employees falsified records to cover up the delays.
The Ebola virus has the "upper hand" in an outbreak that has killed more than 1,400 people in West Africa, a top American health official said, adding that experts have the tools to stop it. Dr. Tom Frieden, the director of the U.S. Centers for Disease Control and Prevention, is visiting Liberia, Sierra Leone and Guinea, the three hardest hit countries, this week.
The U.N. health agency recommended Tuesday that nations regulate electronic cigarettes and ban them from use indoors until the exhaled vapor is proven not to harm bystanders.In a report to its 194 member nations, the World Health Organization also called for a ban on sales to minors of the popular nicotine-vapor products.